Betting the House on Tocotrienol
David Ho, Chairman and Managing Director, Hovid Berhad
09-Sep-14 10:55
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
In this 2014 interview, David Ho, Chairman and Managing Director of the pharmaceuticals firm Hovid Berhad, discusses global M&A fever in Big Pharma, offers an update on its latest quarterly earnings, its product mix, ongoing industry drivers and challenges and the importance of its ongoing R&D efforts such as its Tocotrienol drug.
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories:
Tags: breakfast grille, breakfast grille, breakfast grille